Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities

NQ Khai, TK Vu - Anti-Cancer Agents in Medicinal Chemistry …, 2024 - ingentaconnect.com
Since coumarin and hydroxamic acid compounds are well-known in medicinal chemistry, a
variety of their derivatives have been highlighted due to their potential uses for plentiful …

Curcumin and colorectal cancer: An update and current perspective on this natural medicine

W Weng, A Goel - Seminars in cancer biology, 2022 - Elsevier
Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression

N Ahangar Davoodi, S Najafi… - Frontiers in cell and …, 2022 - frontiersin.org
Retinoblastoma (RB) is a rare aggressive intraocular malignancy of childhood that has the
potential to affect vision, and can even be fatal in some children. While the tumor can be …

Distant metastasis in colorectal cancer patients—do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review

S Filip, V Vymetalkova, J Petera, L Vodickova… - International journal of …, 2020 - mdpi.com
Colorectal cancer (CRC) remains a serious health problem worldwide. Approximately half of
patients will develop distant metastasis after CRC resection, usually with very poor …

Multi-targeted HDAC inhibitors as anticancer agents: current status and future prospective

VK Patel, E Shirbhate, P Tiwari, R Kore… - Current Medicinal …, 2023 - ingentaconnect.com
Multi-targeted agents can interact with multiple targets sequentially, resulting in synergistic
and more effective therapies for several complicated disorders, including cancer, even with …

Design, synthesis and biological evaluation of novel coumarin-based hydroxamate derivatives as histone deacetylase (hdac) inhibitors with antitumor activities

F Yang, N Zhao, J Song, K Zhu, C Jiang, P Shan… - Molecules, 2019 - mdpi.com
A series of novel coumarin-based hydroxamate derivatives were designed and synthesized
as histone deacetylase inhibitors (HDACis). Selective compounds showed a potent HDAC …

MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway Retraction in/10.3892/or …

L Xu, W Li, Q Shi, M Wang, H Li… - Oncology …, 2020 - spandidos-publications.com
Abstract MicroRNA‑936 (miR‑936) has been reported to play important roles in the
progression of non‑small cell lung cancer and glioma. However, the expression and …

Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies

A Singh, VK Patel, H Rajak - Journal of Molecular Structure, 2021 - Elsevier
Pyrrole is a biologically active scaffold, which itself possess noticeable anticancer activity
against several types of cancer specially leukemia, lymphoma, and myelofibrosis. SAHA and …

Tubulin/HDAC dual-target inhibitors: Insights from design strategies, SARs, and therapeutic potential

Z Zhang, R Su, J Liu, K Chen, C Wu, P Sun… - European Journal of …, 2024 - Elsevier
Microtubules, one of the cytoskeletons in eukaryotic cells, maintain the proper operation of
several cellular functions. Additionally, they are regulated by the acetylation of HDAC6 and …

Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors

LV Bamberg, F Heigwer… - … Journal of Cancer, 2022 - Wiley Online Library
Epigenetic dysregulation is an important feature of colorectal cancer (CRC). Combining
epigenetic drugs with other antineoplastic agents is a promising treatment strategy for …